SOLUTIONS

EVER AFTER FOODS

A landmark collaboration for a cultivated food platform

Ever After Foods is a joint venture with the Tnuva Group, Israel’s largest food producer and a pioneer in the field of alternative proteins.
Announced in early 2022, Ever After Foods will develop, manufacture and commercialize cell-based products for the food industry, bringing sustainable and affordable cultivated food to consumers across the globe.

Pluri (formerly Pluristem) brings nearly two decades of experience in cell technology, cell-based product R&D and in-house manufacturing. This is well-aligned with Tnuva Group’s nearly 100 years of experience as an industry leader in consumer-packaged goods, R&D, consumer branding, marketing and global sales and distribution.

Pluri and Tnuva Group may expand the collaboration to include cultivated dairy and fish products by establishing separate, new ventures.

…We chose to collaborate with Pluri (formerly Pluristem) because we believe it owns one of the most advanced cell production technologies in the world.
We expect the collaboration between the companies to revolutionize the cultivated food industry and develop the next generation of alternative proteins.

Eyal Malis, CEO Tnuva Group

Let’s Work Together

Contact us today to explore a partnership tailored to your current and future clinical drug product manufacturing needs.

©2023 Pluri Inc.

©2023 Pluri Inc., its logo, brand, product, and process names appearing in this issue are the trademarks of Pluri™ Inc. or its affiliated companies. All other brand, product, and process names appearing are the trademarks of their respective holders. Reference to or use of a product, or process other than those of Pluri™ Inc. does not imply recommendation, approval, affiliation, or sponsorship of that product, or process by Pluri™ Inc. Nothing contained herein shall be construed as conferring by implication, estoppel, or otherwise any license or right under any patent, copyright, trademark, or other intellectual property right of Pluri™ Inc. or any third party, except as expressly granted herein.  All information herein is for general information only and is subject for change without notice.

NAME

Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.